Phase 2 Focal Onset Seizure Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Focal Onset Seizures
Supernus Pharmaceuticals, Inc.216 enrolled1 locationNCT06798896
Recruiting
Phase 2
A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures
seizureEpilepsyRefractory Focal Epilepsy+3 more
Rapport Therapeutics Inc.30 enrolled7 locationsNCT07219407
Recruiting
Phase 2
SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures
Focal Onset Seizures
Supernus Pharmaceuticals, Inc.100 enrolled1 locationNCT07141329
Recruiting
Phase 2
An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
Focal Onset SeizurePrimary Generalized Epilepsy
Praxis Precision Medicines50 enrolled11 locationsNCT06908356